29 C The Economic Times
Elections 2026Health & Fitness / The Economic Times
2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decades of growth from importing medicines to global leadership. The nation now supplies a significant portion of the world's generic medicines and vaccines. The Covid-19 pandemic further showcased the industry's manufacturing capabilities globally. Government initiatives now aim to foster innovation and high-value biopharmaceutical production.
Emcure Pharmaceuticals reported a 23% revenue increase in the first quarter. Ebitda grew 25.8% with improved margins, reflecting productivity gains. Net profit saw a significant 36.2% rise during the period. The company began its five-year plan on a strong footing for FY27. Emcure also completed the acquisition of a minority stake in Gennova Biopharmaceuticals.
Manipal Hospitals plans future growth through acquisition integration and market expansion. The company will focus on improving clinical complexity and patient experience. Large hospital acquisitions are becoming scarce, shifting focus to organic growth. Manipal aims to increase bed capacity and utilization over the next three years. Affordability will be managed by enhancing complexity rather than raising prices.
Global investment firm KKR has acquired Medicover India's hospital network for $1.39 billion. This acquisition marks KKR's third hospital purchase in recent years. Medicover India operates 24 multi-specialty hospitals across South and West India. The European healthcare chain will now focus its operations solely within the continent. This transaction allows Medicover to strengthen its financial position and pursue European growth.
We have begun FY27, the second year of our five-year planon a strong footing. FY26 was about putting the building blocks in place across teams, portfolio, integration and operating discipline. FY27 is about delivery, and Q1 is an encouraging early signal, said Satish Mehta, Managing Director and CEO Emcure Pharmaceuticals.